logo 03 logo 05 logo 07

Communiqué de presse

TargEDys and Inserm Transfert on behalf of Rouen Normandy University and Rouen University Hospital (CHU) sign an exclusive international licensing agreement on a patent portfolio in microbiome-based research.

 

Read more


Press release

HalioDx SAS, an immuno-oncology diagnostic company, Inserm and Inserm Transfert, its subsidiary, today announced the commercialization of Immunoscore® Colon, a unique diagnostic assay for guiding therapeutic decisions in colon cancer.

Learn More




INSERM TRANSFERT
Paris Biopark - 7 rue Watt - 75013 PARIS
Phone  +33 (0)1 55 03 01 00
Fax +33 (0)1 55 03 01 60
contact@inserm-transfert.fr